Analysis of mig-10, a Gene Involved in Nervous System Development in Caenorhabditis elegans by Stovall, Elizabeth L.
Worcester Polytechnic Institute
Digital WPI
Masters Theses (All Theses, All Years) Electronic Theses and Dissertations
2004-04-30
Analysis of mig-10, a Gene Involved in Nervous
System Development in Caenorhabditis elegans
Elizabeth L. Stovall
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/etd-theses
This thesis is brought to you for free and open access by Digital WPI. It has been accepted for inclusion in Masters Theses (All Theses, All Years) by an
authorized administrator of Digital WPI. For more information, please contact wpi-etd@wpi.edu.
Repository Citation
Stovall, Elizabeth L., "Analysis of mig-10, a Gene Involved in Nervous System Development in Caenorhabditis elegans" (2004). Masters
Theses (All Theses, All Years). 565.
https://digitalcommons.wpi.edu/etd-theses/565
Analysis of mig-10, a Gene Involved in Nervous 
System Development in Caenorhabditis elegans 
 
By 
Elizabeth L. Stovall 
 
A Thesis Submitted to the Faculty of  
 WORCESTER POLYTECHNIC INSTITUTE 
In partial fulfillment of the requirements for the  
Degree of Master of Science in Biology and Biotechnology 
 
 
Elizabeth L. Stovall 
April 30, 2004 
 
Approved by: 
 
 
Elizabeth Ryder, Ph.D.              Jill Rulfs, Ph.D.  David Adams, Ph.D. 
Major Advisor               Committee Member Committee Member 
WPI                WPI   WPI 
 ii 
Abstract 
 
 The mig-10 gene in C. elegans is required for proper axon guidance and/or cell migration 
of certain neurons during development.  In mig-10 (ct41) mutant worms, there is incomplete 
migration of the anterior lateral microtubule cells (ALMs), hermaphrodite specific neuron (HSN), 
left coelomocyte cells (ccL), and canal associated neuron (CAN) (Manser and Wood, 1990).  The 
mig-10 (ct41) mutation also causes axon guidance defects in the IL2 neurons, and it enhances 
unc-6 defects in the axon guidance of the anterior ventral microtubule cell (AVM) (Rusiecki, 
1999; C. Quinn, personal communication).   
 mig-10’s function in axon guidance and neuronal migration is unknown, but is believed 
to be involved in a signal transduction pathway that uses a G-protein, such as ras.  The two mig-
10 transcripts discussed in this thesis, mig-10 A and mig-10 B, encode proteins that are similar to 
Grb-7 and Grb-10 proteins, which are also believed to function in a signal transduction pathway 
(Manser et al., 1997).  One of these similarities is the presence of a proline-rich region, which 
may be used to bind another protein (Manser et al., 1997).  The MIG-10 A protein has an 
additional proline region, compared to MIG-10 B, which may indicate that the MIG-10 A and B 
proteins are utilized in different cells, or at different developmental stages.         
 As a first step in learning where MIG-10 is expressed, mig-10 (ct41) mutant worms 
containing a wild-type mig-10 B::GFP fusion were constructed.  Rescue of the mutant phenotype 
would indicate that the expression pattern of the transgene was similar to that of the endogenous 
gene.  As this experiment did not allow for rescue, even after integration of the construct, a strain 
of worms containing a mig-10 promoter::GFP transgene was used.  Preliminary observations of 
this strain indicated that mig-10 is expressed in neuronal tissue.   
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 The AIY neurons were observed in wild-type and mig-10 (ct41) worms to determine if 
they are affected by the mig-10 mutation as previously reported (O. Hobert, personal 
communication).  As no difference was detected, the AIYs were not used in any further 
experiments. 
 In order to determine which cells require functional MIG-10 protein for the proper 
development/migration of neurons to occur, mig-10 (ct41) worms containing mec-3 
promoter::mig-10 A or B cDNA transgenes were constructed.  The mec-3 promoter drives 
expression of the mig-10 cDNA in the ALM neurons and other touch cells early in the 
development of the embryo.  If these transgenes rescued the ALM migration defect, then mig-10 
would be acting cell autonomously in ALM.  Partial rescue was obtained, which may be due to 
the need for both of the mig-10 transcripts to be expressed in the same cell; alternatively, one or 
both transcripts may need to be expressed in a cell nonautonomous fashion in addition to being 
expressed cell autonomously.  Low production of the rescuing protein, or expression of the 
protein at a later developmental stage than is needed for rescue to occur, may also have been the 
cause of the partial rescue.   
 Future work in this area includes putting mig-10 promoter::mig-10 A or B cDNA in mig-
10 (ct41) background to investigate if the different transcripts rescue different aspects of the mig-
10 phenotype.  The mig-10 A and mig-10 B cDNA constructs could also be expressed in the same 
worm in an attempt to correct for partial rescue that may be due to the lack of both MIG-10 
proteins. 
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 “ It is better to trust in the LORD than to put confidence 
in man.”  – Psalms 118: 8 
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Introduction   
 
 During the development of an organism, the formation of neuronal connections is made 
possible, in part, by various molecular cues within the environment of the developing neurons.  
This process, in which axons are guided along a specific pathway to a final destination through 
their response to a molecule in the environment, is known as axon guidance.  At the developing 
end of the axon is the growth cone, the part of the axon that receives ligands (molecular cues), 
and responds appropriately, guiding the axon in a specific direction (fig. 1).  While some 
molecules are responsible for attracting neurons, others repel neurons.  Netrins, for example, may 
repel or attract neurons.  Ephrins, semaphorins, and slits may serve as adhesive or attractive 
molecules, but are often repellants.  In addition to axon guidance, these molecules, or ligands, aid 
various cells in morphogenesis and cell migration (Yu and Bargmann, 2001).    
 
   
Figure 1:  Illustration of a Neuronal Growth Cone.  Bear, Connors, and Paradiso (2001) 
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When ligands interact with their receptors, the growth cone will respond as a result of a 
signaling cascade.  Receptor signaling alters the growth cone’s stability and initiates its change 
into an axon shaft through the conversion of the growth cone’s actin cytoskeleton (Yu and 
Bargmann, 2001).   
 
Mechanisms of Axon Guidance 
The goal of this project was to elucidate the role of the mig-10 gene in cell migration and 
axon guidance during the development of the nervous system in C. elegans.  mig-10 is thought to 
be involved in a signal transduction pathway with a member of the G-protein superfamily that 
includes both ras and rho-like GTPases.  The Rho family of GTPases such as Cdc42, Rac, and 
RhoA are part of the signaling cascade for some guidance receptors (Patel and Van Vactor, 
2002).  Rho GTPases are activated when guanine nucleotide exchange factors (GEFs) support the 
exchange of GDP for GTP.  These GTPases are inhibited when GTPase activating proteins 
(GAPs) promote GTP hydrolysis.  The extension of the growth cone’s filopodia and lamellipodia 
are made possible through the activation of Cdc42 and Rac, respectively (Patel and Van Vactor, 
2002).  The creation of stress fibres, as well as the contractibility of actinomysin occurs through 
RhoA, allowing for the growth cone to collapse and be repelled (Patel and Van Vactor, 2002).    
 An example of how GTPases are involved in signal transduction can be seen in the 
interaction between RhoA and the Eph receptor.  When an ephrin ligand binds to the extracellular 
portion of an EphA4 receptor, the intracellular portion of the receptor - which contains a tyrosine 
kinase domain - activates ephexin.  Ephexin then activates RhoA.  Ephexin is an Eph-interacting 
exchange factor; more specifically, it is a GEF that interacts between the cytoplasmic domain of 
the EphA4 receptor and Rho GTPases.  As ephexin activates RhoA by exchanging GDP for GTP, 
it also reduces the stimulation of Cdc42 and Rac1.  Thus, ephexin is responsible for the collapse 
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of the growth cone.  Without any stimulation, ephexin is bound to EphA4 and is able to allow for 
the growth cone’s extension by activating Cdc42 and Rac1 (Patel and Van Vactor, 2002).  
 Alternative splicing can also help to regulate a response to a guidance cue.  Eph receptor 
signaling typically results in a repelling response; however, alternative splicing can result in an 
EphA7 without a tyrosine kinase domain; this truncated protein prevents the full-length EphA7 
from being phosphorylated.  The lack of this catalytic activity allows for adhesion, rather than 
repulsion (Yu and Bargmann, 2001). 
 Axon guidance can be affected by the presence of more than one receptor.  For example, 
the combination of various receptors can allow for more specific ligand-binding and alter the 
growth cone’s response.  A receptor can also suppress another receptor.  Another possible 
silencing mechanism is for a signaling molecule downstream of the receptors to silence another 
downstream molecule.   As an example, the chemokine SDF-1 ordinarilly activates the CXCR4 
receptor.  When the transmembrane protein ephrin B binds to the receptor CXCR4, a G-protein, 
which is bound to CXCR4, is activated.  If ephrin B, which is downstream of CXCR4, receives a 
signal from its receptor, eph-B, ephrin B will bind to a regulator of G-protein signaling (RGS) 
instead of the CXCR4 receptor.  This inactivates the G-protein.  This inactivation will keep the 
granular cell, in which these receptors are found, from being guided towards SDF-1 (Yu and 
Bargmann, 2001).   
 As the location of molecular cues depends partially on the location of the cells from 
which they originate, the guidance or migration of some cells depend on the location of other 
cells.  For example, the hermaphrodite specific neuron (HSN) migrates from the tail of the C. 
elegans embryo to a more anterior location near the canal associated neuron (CAN) (fig. 2A).  If 
the CAN does not migrate posteriorly from its original location in the head of the embryo, HSN 
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will be found further anterior.  Thus, the migration of HSN depends on some molecular cue from 
CAN (Forrester and Garriga, 1997). 
 
mig-10 Gene 
In order to gain a better understanding of the nervous system’s development, the genes 
that regulate this development must be studied.  One such gene is the mig-10 gene in C. elegans, 
which is required for the proper migration and/or axon guidance of certain neurons (Manser and 
Wood, 1990).       
Some of the neurons in mig-10 (ct41) mutant animals are unable to complete their normal 
migrations (fig. 2B).  Ninety-four percent of the anterior lateral microtubule cells (ALMs) and 
80% of the hermaphrodite specific neurons (HSN) display an incomplete migration in mig-10 
(ct41) mutant worms.  Other affected neurons displaying partial penetrance include left 
coelomocyte cells (ccLs) and canal-associated neurons (CANs); only 73% of the ccLs and 61% of 
the CANs experience an incomplete migration (Manser and Wood, 1990).  As the mutation 
affects neuronal migration in more than one direction (anteriorward and posteriorward), the mig-
10 (ct41) mutation probably affects some mechanism in cell migration rather than a directional 
signal to which the migrating cells react (Manser et al., 1997). 
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Figure 2:  Schematic of Embryonic Neuronal Migrations in C. elegans.  A) CAN neuron migrates 
posterior, HSN anterior.  A, anterior region of embryo; P, posterior region.  From Forrester and Garriga 
(1997).  B) ALM, CAN, and HSN migrations projected onto L1 larvae.        , area where vulva will 
develop.  From Manser and Wood (1990).    
 
In addition to neuronal migration, the mig-10 mutant gene affects axons.  The IL2 axons 
in mig-10 (ct41) animals don’t always form a loop at the nerve ring, as th ey should (Rusiecki, 
1999).  The mig-10 mutation also appears to enhance an axon guidance defect of AVM neurons 
in unc-6 animals (C. Quinn, personal communication). 
The only phenotype known to be completely penetrant within the mig-10 (ct41) mutant  
is a foreshortening of the processes of the excretory cells.  Rather than extending almost to the 
posterior end of the worm, the cells in mutant worms come to an end near or anterior to the vulva 
(Manser et al., 1997). 
 Though the excretory cells are affected by the mig-10 (ct41) mutation, the wild-type 
phenotype of these cells cannot be rescued by expressing the wild-type gene only in these cells.  
In addition, the wild-type phenotype can be rescued by expression only in other cells (Manser et 
al., 1997).  This indicates that, with regard to the excretory cells, the mig-10 gene is cell 
Head 
A 
B 
A 
P 
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nonautonomous.    As cells affected by the mig-10 (ct41) mutation tend to be located in the 
vicinity of the epidermal basal lamina, the mig-10 gene may be expressed in epidermal tissue 
(Manser et al., 1997). 
 Two protein isoforms, MIG-10 A and MIG-10 B, can be produced by the mig-10 gene 
(fig. 3).  Protein predictions from the cDNA indicate that six hundred twenty-nine amino acids 
from the carboxy-terminal of the MIG-10 B protein are also found in the MIG-10 A protein 
(Manser et al., 1997).  MIG-10 B consists of 650 amino acids, encoded in exons 1b through 9.  
MIG-10 A consists of 667 amino acids, encoded in exons 1a through 9 (Manser et al., 1997). 
In the mig-10 (ct41) allele, a base pair change, resulting in an amber stop codon, occurs 
within exon 3 of the mig-10 gene (fig. 3).  This termination in the reading frame should result in 
the severe truncation of the MIG-10 proteins and is very likely a null mutation (Manser et al., 
1997). Genetic support for mig-10 (ct41) being a null comes from experiments comparing 
homozygous and hemizygous mig-10 (ct41) mutant worms for certain phenotypes, including egg-
laying defective (Egl) and withered tail phenotype, locations of migratory nuclei in L1s, and the 
ability of adult worms to live.  No major differences were observed between the two genotypes; 
thus, the mig-10 (ct41) mutation likely results in a completely, or mostly, nonfunctional mig-10 
gene (Manser and Wood, 1990). 
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Figure 3:  Map of mig-10 A & mig-10 B.  mig-10 B (top) has an alternative first exon, which is 
downstream of mig-10 A’s first exon (bottom).  Also displayed is the Grb-Mig (GM) domain, and the 
Pleckstrin Homology (PH) domain.  The mig-10 (ct41) allele is the result of a nonsense mutation in the 
third exon, as shown here.  Proline-rich regions are also found at both ends of MIG-10, with an additional 
proline region in MIG-10 A.  Schematic taken from Manser et al., (1997). 
 
 The predicted MIG-10 protein shares similarities with Grb 7 and Grb 10, members of 
SH2 domain proteins that are believed to function in signal transduction pathways (fig. 4)  
(Manser et al., 1997).  The GM (Grb and Mig) regions of these proteins contain the most 
similarities.  The Pleckstrin Homology (PH) domains, found within the GM region, are about 
33% identical between Grb 7 and mig-10.  Between mig-10 and Grb 10, the PH domains are 
about 36% identical. These domains are involved in interactions between molecules such as 
protein-lipid and protein-protein.  It has been suggested that the PH domains might aid in steering 
the proteins to the membranes (Manser et al., 1997).  While the function of the PH domain is 
uncertain, it has been found in several proteins involved in cytoskeletal activity or cell-signaling.  
These domains contain a structure comparable to certain phosphotyrosine binding (PTB) domains 
(Manser et al., 1997).   
 8 
In addition to the PH region, the GM domains of the Grb and MIG-10 proteins contain a 
ras-associating domain (fig. 4) (Wojcik et al., 1999).  Ras is a member of the G protein family 
that is found in many signal transduction pathways known to moderate axon guidance and cell 
migration (Forrester and Garriga, 1997).   
 The MIG-10 and Grb proteins both contain regions rich in proline (fig. 4, black stars).  
These regions are located in the amino termini within Grb 7 and Grb 10.  In the MIG-10 proteins, 
they are located in both termini.  These regions may be involved in protein-protein interactions 
(fig. 4) (Manser et al., 1997).  
 The SH2 region in Grb 7 and Grb 10 proteins interacts with a phosphotyrosine that is part 
of a tyrosine kinase receptor (De Vet et al., 2003; Giovannone et al., 2003).  The ras-associating 
domain in the Grb proteins allows Grb to link the tyrosine kinase receptor to ras. 
 MIG-10 proteins don’t have an SH2 domain, and thus, cannot directly bind 
phosphotyrosine (fig. 4) (Manser et al., 1997).  The proline-rich regions of MIG-10 contain a 
PXXP consensus sequence, which is necessary for the binding of a protein to an SH3 protein 
domain; SH3-containing proteins are found in signal transduction pathways (Manser et al., 1997).  
An example of such a protein is Grb-2, which contains two SH3 domains and an SH2 region 
(Gomperts, 2003).       
A potential model of MIG-10’s f unction is seen in figure 5.  A protein, like Grb-2, may 
act as an adaptor, linking a phosphotyrosine (through an SH2 domain) to MIG-10 (through an 
SH3-proline interaction), which can then interact with ras. 
The MIG-10 A isoform may be expressed at another developmental stage, used in 
different cells, or utilized in a different manner from the MIG-10 B isoform, as MIG-10 A has an 
extra proline-rich region.  This additional proline region not found in MIG-10 B may allow for 
the binding of more, or different, SH3 domain proteins.     
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Figure 4:  Comparison of MIG-10 to Grb 7 & Grb 10.  In addition to the PH domain (white in diagram), 
a considerable amount of similarity can be found within the Ras associating domains (RA, black in 
diagram).   This region, which is part of the GM domain of the Grb and MIG-10 proteins, is amino-terminal 
to the PH domain.  Between MIG-10 and Grb-7, these domains are about 29% identical.  These domains 
are about 34% identical between MIG-10 and Grb-10 (Manser et al., 1997).  BPS, Between Pleckstrin 
Homology;  PH, plextrin homology domain; GM, Grb and MIG; SH2, src homology domain-2.  Illustration 
from Wojcik et al. (1999). 
 
 
 
 
Figure 5:  Proposed Model of Signal Transduction Pathway with MIG-10 and Grb-2.  The Grb-2 
protein, consisting of SH2 and SH3 domains, links the proline region of MIG-10 with the phosphotyrosine 
of an activated tyrosine kinase receptor.  MIG-10’s ras -associating domain (RA) interacts with ras.   
SH2 
SH
3 
ras 
Grb-2 
proline 
MIG-10 
ligand 
phosphotyrosine 
Extracellular 
matrix 
Plasma 
membrane 
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Project Goals 
MIG-10 is predicted to be a cytoplasmic protein with domains involved in signal 
transduction.  In the simplest model, such a molecule would be expected to be cell autonomous.  
As previously mentioned, however, mig-10 is cell nonautonomous to the excretory canal (Manser 
et al., 1997).  One part of this project was to determine how mig-10 works with regard to neurons 
– if, for example, mig-10 is also cell nonautonomous to neurons.  Observing the expression 
pattern of mig-10 in C. elegans might help to resolve this matter.  Thus, one goal of this project 
was to construct a strain containing a mig-10 promoter followed by mig-10 genomic DNA and 
GFP, in order to determine what cell types express mig-10. 
 While mig-10 is cell nonautonomous to the excretory canal, it’s possible that it could be 
cell autonomous to the neurons that it affects.  To investigate this possibility for the ALM 
neuronal migration, constructs were designed to express wild-type mig-10 early in the ALMs of 
mig-10 mutant worms.  Transgenic strains containing these constructs were examined for rescue.     
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Methods 
 
DiO Staining of IL2 Neurons  
Fifty millimolar calcium acetate (CA) was used to pipette a growing worm culture from a 
plate into a 1.5 mL microfuge tube.  The supernatant was pipetted from the tube after the worms 
settled to the bottom, which took about five minutes.  The worms were rinsed with 50 mM 
calcium acetate.  After the worms settled in the tube, and the supernatant was taken off a second 
time, one milliliter of 10 µg/ml DiO in 50 mM CA was added.  The tubes were rotated for two 
hours on a Labquake® Shaker; after which, the worms were allowed to settle.  Distilled water was 
used to rinse the worms twice.  The worms were transferred to a plate with E. coli for anywhere 
between 30 minutes and overnight, and were stored in a dark area.  Worms were then washed off 
the plate with M9 solution, and transferred to a microfuge tube, where they settled to the bottom.  
The M9 solution consisted of 22 mM KH2PO4, 42 mM Na2HPO4, 86 mM NaCl, and 1 mM 
MgSO4.     
As the worms were settling, microscope slides with agarose pads were prepared.  A Pasteur 
pipette was used to place a drop of melted 2% agarose containing 10 mM azide onto a 24 x 60 
mm microscopic slide, which had been placed parallel between two other slides.  Another slide 
was dropped on top of the agarose so that it was resting on all of the other slides.  This flattened 
the agarose, but kept it from being too thin.   
The top slide was pulled along the bottom slide until the two were separated, leaving the 
agarose pad on one slide.  Three microliters of the worms from the tube were transferred to the 
pad, and a 24 x 24 coverslip was placed on top of the pad.  The worms were observed using a 
fluorescein filter on an Axioskip compound microscope equipped with epifluorescence.            
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Genetic Crosses 
In order to construct C. elegans strains carrying various integrated marker GFP arrays in a 
mig-10 (ct41) background, the strategy in figure 6 was used. 
 
                                                
Figure 6:  Strategy for Integrating Marker GFP Array into mig-10 (ct41) Background.  In order to put 
a GFP array, which acts as a marker, into the mig-10 (ct41) background, a hermaphroditic worm containing 
the marker had to first be mated with a male.  Mating one strain to a male allows the genes of the first strain 
to be transferred to another strain.  Progeny males containing the marker were then mated to mig-10 (ct41) 
mutant hermaphrodites, yielding progeny that were heterozygous for both the marker and the mutant allele 
of mig-10.  The self-fertilization ( ) of this last generation of worms resulted in progeny that were 
homozygous for the mig-10 (ct41) gene, but probably still heterozygous for the marker.  The self-
fertilization of this generation produces worms that are homozygous for both the mig-10 (ct41) gene, and 
the marker. 
 
In some of the crosses, worms containing two extrachromasomal arrays were desired.  For 
example, worms containing fluorescent excretory cells (due to the transgene bgIs312) were mated 
with mig-10 (ct41); mpEx16 worms (table 1 and 2) in order to obtain bgIs312; mig-10 (ct41); 
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mpEx16, using the same strategy as in figure 6, but retaining both marker arrays.  The bgIs312 
strain was also mated with mig-10 (ct41); mpEx15 and mig-10 (ct41); mpEx17 (table 1 and 2).  
The fluorescent excretory cells were observed by placing the worms under a Zeiss dissection 
microscope equipped with epifluorescence.   
 
Confirming that Worms are Homozygous for mig-10 (ct41) Mutation 
 After the final step of a cross in which one genotype was put into a mig-10 (ct41) 
background, the gene was confirmed to be homozygous for the mig-10 (ct41) mutation through 
10 worm PCR, in which the region of the mutation was amplified.     
 Before PCR could be performed, the worms were lysed in order to make their DNA 
available for PCR.  Several worms (ranging from about 5 worms to 20 or more) were taken from 
a plate with very little or no E. coli remaining, and were put into the cap of a PCR tube containing 
2.5 µl of a digest buffer, which consisted of the following ingredients:  50 mM KCl, 10 mM Tris 
(pH 8.2), 2.5 mM MgCl2, 0.45% NP-40, 0.45% Tween 20, 0.01% gelatin, and 0.15 mg/ml 
Proteinase K.  The tube was closed and spun at top speed in a microcentrifuge for about 10 
seconds to pellet the worms.  Fifty to one hundred microliters of mineral oil was pipetted on top 
of the pelleted worms.  The tube was then placed at -80°C for at least 30 minutes, but could be 
stored indefinitely at -80°C.  The frozen tubes were transferred to the thermocycler, which ran for 
an hour at 65°C (lysis), 15 minutes at 95°C (inactivation of Proteinase K), and then at 4°C until 
the next step. 
Shortly before/during the holding stage (4°C) of the lysis reaction, a PCR master solution 
was prepared, which consisted of the following for each sample in the thermocycler:  11 µl sterile 
water, 2.5 µl 10X Long PCR Buffer 3, 2.5 µl 2.5 mM dNTP mix, 2.5 µl 3 µM top primer, 2.5 µl 
bottom primer, and 1.5 µl Taq polymerase (5 U/µl).  The 10X Long PCR Buffer 3 was taken 
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from the Expand Long Template PCR System, manufactured by Roche Diagnostics.  Twenty-two 
and a half microliters of the master mix was added to each tube in the thermocycler.  The tube’s 
contents were mixed by flicking the tube, which was then microcentrifuged for a few seconds.  
The tube was returned to the thermocycler, which ran for 10 minutes at 94°C (initial denaturing).  
The thermocycler then went through 30 cycles of the following:  30 seconds at 94°C (denature), 1 
minute at 60°C (anneal), and 2 minutes at 72°C (primer extension).  The final step (final 
extension) was at 72°C for 10 minutes; after which, the samples were held at 4°C until they were 
either used or transferred to a refrigerator or freezer. 
The replicated DNA was digested with Hpy188I restriction enzyme and run on a 0.8% 
agarose gel at 70 volts for 1.5 to 2 hours.   As the mig-10 (ct41) mutation causes a RFLP, 
Hpy188I-digested wild-type mig-10 DNA will yield 79 bp, 190 bp, 192 bp, and 366 bp fragments 
(Appendix A).    A mig-10 (ct41) mutant gene digested with Hpy188I will also yield the 79 bp 
and 190 bp fragments, but, instead of a 192 and 366 bp fragment, will produce a 558 bp fragment 
(Appendix A).   
 
Integrating Plasmid DNA into the Genome of C. elegans 
To integrate the wild-type mig-10 B genomic DNA (mpEx15) into the genome of the mig-
10 mutant worms, a protocol from Melissa Hunter-Ensor of Massachusetts Institute of 
Technology was used.  About twenty 60 mm2 plates of mixed stage cultures mig-10 (ct41); 
mpEx15 worms were treated with 3600-4800 Rads of gamma radiation (done at UMass Medical 
School).  The irradiated transgenic L4 hermaphrodites were transferred to 20 agar plates 
containing E. coli, five worms per plate.   About ten days later, a chunk from each of the 20 plates 
(which were starved) was transferred onto a new E. coli-spotted agar plate.  After the worms grew 
up on these new plates, 20 of the transgenic worms from each plate were individually plated, 
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resulting in 400 singled worms.  Worms were picked only if most of their intestinal cells 
expressed the co-transformation marker elt-2::GFP.  These worms were allowed to grow up and 
reproduce; after which, each of the 400 plates were checked for worms in which at least half of 
the population had the majority of their intestinal cells expressing elt-2::GFP.  Eight transgenic 
worms were isolated from each plate that fit this description.  If a newly isolated worm was 
observed to have progeny in which 100% of them were transgenic, this line of worms was 
considered to have the mpEx15 (mig-10 B DNA) integrated into the worms’ genomic DNA.  Only 
one line, mpIs5; mig-10 (ct41), was isolated using this integration procedure.   
 
Constructing mig-10 A & mig-10 B cDNA with mec-3 Promoter 
 The mig-10 cDNA needed to be inserted into the second multiple cloning site (MCS II) 
of pPD57.56 between NheI and KpnI.  In order to isolate the mig-10 A and mig-10 B cDNAs from 
their original plasmid vectors ((pCRII-TOPO) – a generous gift from Chris Quinn), the restriction 
enzymes KpnI and NheI were used (Appendix B).  The spliced coding regions for mig-10 A and B 
(found through http://www.wormbase.org/db/gene/gene?name = mig-10) were analyzed in Clone 
Manager to ensure that the mig-10 A and B cDNAs are not cut by either NheI or KpnI.  The 
digested DNA was run on a TAE agarose gel.  The DNA bands at 2.0 kb were extracted from the 
gel and purified using the Eppendorf Perfectprep Gel Cleanup kit.  The mec-3 vector contained 
two KpnI sites.  Thus, a partial digest, using KpnI, was performed on pPD57.56 (containing the 
mec-3 promoter region); this digest was run on a TAE agarose gel.  A 5.0 kb DNA band, resulting 
from either one of the KpnI sites being cut, was extracted from the gel and purified, also with the 
use of the Eppendorf Perfectprep Gel Cleanup kit.  This 5.0 kb DNA was digested with NheI, 
yielding (among other things) a 5.0 kb band, which was also purified from its TAE agarose gel.  
T4 DNA Ligase was used to ligate the cut pPD57.56 with the mig-10 A cDNA, and (in a separate 
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ligation) pPD57.56 with mig-10 B cDNA.  These ligation products were used in transforming 
DH5α E. coli cells.   
The plasmid DNA obtained from the resulting colonies (Appendixes C and D) (after the 
miniprep was performed) was digested with the restriction enzyme SspI, which was predicted to 
produce the following DNA fragments:     
 
 
pPD57.56     pPD57.56 + mig-10 A     pPD57.56 + mig-10 B 
digested with SspI yields: digested with SspI yields:            digested with SspI yields: 
2455 (bp)        901 (bp)   ~2180 (bp) 
2833    ~1335    ~2180 
     ~2220        2833 
    
     2833 
 
The two appropriately sized bands for the pPD57.56 vector with mig-10 B cDNA were achieved 
(Results, lane 4 of figure 13S), as well as the four bands for pPD57.56 + mig-10 A (Results, lanes 
5-8 of figure 13S). 
As there was some uncertainty - due to partial digests - in regards to whether or not the 
mig-10 A (or mig-10 B) DNA fragments were contained within the pPD57.56 vector DNA, the 
HindIII restriction enzyme was used to confirm the presence of the mig-10 cDNA.   
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Clone Manager was used to predict the following fragments that would be produced from 
a HindIII digest:  
 
pPD57.56  pPD57.56 + mig-10 A  pPD57.56 + mig-10 B 
(digested with HindIII)  (digested with HindIII)  (digested with HindIII) 
~1.3 (kb)    1.15 (kb)               1.15 (kb) 
~4.0                1.31                1.31  
1.57  1.53 
3.32  3.32     
 
Figure 13H (Results, lanes 4, 6-9) confirms that the mig-10 insert was present in these DNA 
samples. 
 
Transformation and Minipreps  
Using sterile technique throughout this protocol, five microliters of plasmid prep were added 
to 100 µL of DH5α competent cells thawed on ice.  This solution was incubated on ice for 30 
minutes.  The cells were resuspended and heat-shocked at 37°C for 2 minutes.  Half a milliliter of 
LB media, which had been pre-warmed to 37°C, was added to the tube containing the cells.  After 
gently mixing the cells, they were incubated for 1 hour at 37°C, and then resuspended.  Ten 
microliters of the resuspended cells were spread over a plate containing 50 µg/mL of ampicillin 
or kanamycin; 100 µL of resuspended cells were placed onto another ampicillin (or kanamycin) 
plate.  The remaining cells were spun down, and supernatant was removed.  A drop of LB media 
was used to resuspend the cells.  These suspended cells were spread over a third ampicillin (or 
kanamycin) plate.  The plates were incubated overnight at 37°C. 
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Five tubes, each containing five milliliters of LB media and 50 µg/ml ampicillin or 
kanamycin, were inoculated with bacteria from five individual colonies from one of the plates 
grown overnight.  These tubes were incubated overnight with shaking at 37°C.  In order to freeze 
a sample of the transformed bacteria, one milliliter of the bacterial broth was added to one 
milliliter of 50% glycerol; this mixture was stored at -80°C. 
The following day, a QIAprep® Spin Miniprep Kit (250) was used to isolate plasmid DNA 
from the bacterial broth.  A restriction digest was performed on the DNA obtained from the 
miniprep, which was then run on an agarose gel to confirm that the appropriate DNA had been 
cloned.    
 
Preparation of DNA for Injection 
 Before DNA injections could be made, five tubes (each containing five milliliters of LB 
media plus 50 µg/mL of ampicillin) were inoculated with DH5α E. coli cells containing the 
cloned DNA of interest.  After incubating at 37°C overnight, plasmid isolation was performed on 
these cultures.  A restriction digest was performed on the combined samples, which was then run 
on an agarose gel to confirm the DNA of interest had been obtained.  The concentration of the 
DNA from the combined samples was checked.   
 To precipitate the DNA, one-tenth volume of 1 M potassium acetate (pH 7.4) was added 
to the sample.  Two volumes of 100% ice-cold ethanol were added to the solution, which was 
then placed at -80°C overnight.  The next day, the solution was spun down at the highest setting 
in a microcentrifuge at 4°C for 30 minutes.  The supernatant was decanted, and the pellet was 
gently washed with 70% ethanol.  The tube containing the washed pellet was inverted, and 
allowed to dry on the bench top overnight.  The following day, the pellet (which may/may not be 
visible) was resuspended in 50 µl of 1X injection buffer and placed at 4°C overnight.  The 10X 
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injection buffer contained 20% polyethylene glycol, 200 mM potassium phosphate (pH 7.5), and 
30 mM potassium citrate (pH 7.5).  The DNA concentration was checked by UV 
spectrophotometry, and the sample diluted to an approximate concentration of 80 ng/µl, or 160 
ng/µl if it was to be combined with other DNA.  When this DNA was not being used, it was 
stored at  -80°C.  Co-transformation markers were typically injected at a concentration of 80 
ng/µl.  Rescuing DNA constructs were also injected at 80 ng/µl, except in the case of the mec-
3::mig-10 A cDNA construct, where embryos containing the extrachromasomal arrays failed to 
hatch.  The concentration of the co-transformation marker (pflp-20) was kept at 80 ng/µl, but the 
mec-3::mig-10 A cDNA construct was reduced to 40 ng/µl.   
 
Preparation of Microinjection Needles 
 In order to make the needles used to inject DNA into C. elegans, 1.0 mm glass capillary 
tubes were placed in a micropipette puller (World Precision Instruments), which pulled a single 
capillary tube into two capillary tubes – each one having a fine, pointed end.  The settings used to 
pull the tubes were typically 8.5 for heat, and a delay of 4.  As these pointed ends had no opening, 
the tip of the pointed end was placed in concentrated hydrofluoric acid (HF); the other end of the 
capillary tube was connected to tubing from a nitrogen gas tank.  With the pressure of the gas at 
about 60 psi, nitrogen was pumped through the needle until bubbles were formed in the 
hydrofluoric acid.  The needle was then transferred to reagent-grade distilled water where the acid 
was diluted as nitrogen was pumped through the needle.  Needles were placed on top of two rows 
of clay in a plastic box for storage.  In some cases, needles were not etched using HF, but had the 
tip broken off simply by inserting the needle into the worm.     
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Injection of DNA into C. elegans 
 The end of a plastic one milliliter syringe was passed over a Bunsen burner until it could 
be drawn out into fine thread-like tubing.  This fine tubing was cut and used to draw up the final 
DNA solution – which had been centrifuged at 14,000 rpm for five minutes to bring any debris 
out of solution.  The DNA was transferred to a microinjection needle, which was carefully tapped 
to eliminate any tiny air bubbles.  A tube was attached to the blunt end of the needle, which 
allowed nitrogen gas (60 psi) to push the DNA solution through the needle with the use of a foot 
pedal.  The needle was attached to the mobile arm of the Zeiss Axiovert S100 microinjection 
microscope.  A microinjection manipulator (type MO-102L) from Narishige Scientific Instrument 
Lab allowed for the positioning of the mobile arm, and thus the needle.  
 A C. elegans worm was mounted onto a 24 x 60 mm coverslip containing a circle of 
dried 2% agarose.  Worms were chosen to be newly gravid, containing only a few eggs or one 
row of eggs in the uterus.  Halocarbon oil (manufactured by Halocarbon Products Corp.) was 
used to pick the worm from the plate to the agarose pad.  As soon as the worm was made 
immobile in its attachment to the agarose (within a drop of hydrocarbon oil), the coverslip was 
transferred to the microinjection microscope, where the DNA solution was injected into the 
worm’s gonad.  The injected worm was carefully transferred with a pick to an agar plate with E. 
coli, where it could produce progeny. 
 
C. elegans Strains and Arrays 
 Several strains and arrays were used throughout this project.  A description of each strain 
and array is seen in tables 1 and 2.  
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Strain Name Genotype Comments 
N2 Wild-type  
BW0315 mig-10 (ct41) Embryonic cell migration defects in ALM, 
HSN, & CAN; withered tail & egg-laying 
defective (Egl); foreshortened excretory 
canal; defective IL2 axons  
OH0099 mgIs18 Integrated GFP construct.  GFP expressed in 
AIYs.   
RY0044 mig-10 (ct41); 
mgIs18 
mgIs18 in mig-10 (ct41) background.  
Constructed by Elizabeth Stovall.  
NN0001 bgIs312 Integrated GFP construct.  GFP expressed in 
processes of excretory cells. 
RY0024 dpy-20 (e1282ts); 
mpIs1 
Contains integrated mig-10 promoter::GFP 
construct.  Backcrossed 4X. 
RY0056 mig-10 (ct41); 
mpEx15 
mig-10 B genomic array.  GFP in intestinal 
cells.  
RY0057 mig-10 (ct41); 
mpEx16 
mig-10 B genomic array.  GFP in intestinal 
cells. 
RY0058 mig-10 (ct41); 
mpEx17 
mig-10 B genomic array.  GFP in intestinal 
cells. 
RY0079 mig-10 (ct41); 
mpIs5  
Integration of mpEx15.  Constructed by 
Elizabeth Stovall & Liz Ryder. 
NY2053 ynIs53 IV; him-5 Integrated flp-20::GFP.  GFP expressed in 
ALMs, AVM, & a few other touch cells. 
RY0096 mig-10 (ct41); 
ynIs53 IV  
ynIs53 IV in mig-10 (ct41) background.  
Constructed by E. Stovall. 
RY0086 mpEx12 “A1” (mig-10 A) Constructed by E. Stovall. 
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RY0087 mig-10 (ct41); 
mpEx12 
mpEx12 in mig-10 (ct41) background.   
“A1; mig-10” Constructed by E. Stovall. 
RY0088 mpEx13 “B1” (mig-10 B) Constructed by E. Stovall. 
RY0089 mig-10 (ct41); 
mpEx13 
mpEx13 in mig-10 (ct41) background.     
“B1; mig-10” Constructed by E. Stovall. 
RY0090 mpEx14 “B8” (mig-10 B) Constructed by E. Stovall. 
RY0091 mig-10 (ct41); 
mpEx14 
mpEx14 in mig-10 (ct41) background.   
“B8; mig-10” Constructed by E. Stovall. 
 
Table 1:  Strain Name, Genotype, and Description of Various Worms Strains 
 
 
mp Arrays Comments 
mpIs1 mig-10 B promoter::GFP;  
pdpy-20 cotransformation marker 
GFP in many neurons. 
Constructed by M. Rivard. 
mpEx15 elt-2::GFP;  
mig-10 promoter::GFP; 
GFP::mig-10 B genomic 
mig-10 B genomic array 
    mpEx16 elt-2::GFP;  
mig-10 promoter::GFP; 
GFP::mig-10 B genomic 
mig-10 B genomic array 
mpEx17 elt-2::GFP;  
mig-10 promoter::GFP; 
GFP::mig-10 B genomic 
mig-10 B genomic array 
mpIs5 Integrated mpEx15 mig-10 B genomic integrated 
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mpEx12 flp-20::GFP; 
 mec-3::mig-10 A cDNA 
GFP in ALMs, AVM, & a few 
other touch cells.  Constructed by 
E. Stovall. 
mpEx13 flp-20::GFP;  
mec-3::mig-10 B cDNA 
GFP in ALMs, AVM, & a few 
other touch cells.  Constructed 
by E. Stovall. 
mpEx14 flp-20::GFP;  
mec-3::mig-10 B cDNA 
GFP in ALMs, AVM, & a few 
other touch cells. Constructed 
by E. Stovall.  
 
Table 2:  Name and Description of Arrays Used in C. elegans 
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Results 
 
Marker strains were constructed to easily identify several aspects of the mig-10 
phenotype.  To determine the expression pattern of mig-10, a transgenic strain containing 
genomic mig-10 fused to GFP was constructed.  To examine cell autonomy in the ALM neurons, 
transgenic strains expressing mig-10 cDNA in the ALM neurons were made.   
 
Analysis of mig-10 Phenotype  
ALM migration 
One partially penetrant phenotype in mig-10 mutants is the incomplete migration of 
anterior lateral microtubule cells (ALMs).  The ALM cell bodies in wild-type animals are 
typically posterior to the AVM cell bodies and anterior to the vulva, while ALM neurons in mig-
10 animals often fail to complete their posterior migration past AVM (fig. 7).  Worms containing 
the ynIs53 transgene, received from Chris Li’s lab, express GFP in the ALM as well as other 
touch cells.  A strain was constructed to visualize the mig-10 (ct41) ALM migration defects by 
crossing mig-10 (ct41) into ynIs53;him-5.   
The relative positions of the ALM and AVM cell bodies were observed in 50 ynIs53; 
him-5 worms.  Worms younger than the L3 stage were not used in these observations because the 
AVM doesn’t migra te to its final location until the L2 stage.  Twelve percent of these wild-type 
worms had at least one misplaced ALM, in which the ALM cell body was either equidistant with 
the AVM cell body from the worm’s nose or anterior to the AVM cell body (fig. 7).  The relative 
positions of ALM and AVM cell bodies were scored in 50 worms that were confirmed to be 
homozygous for the mig-10 mutant gene in the ynIs53 background.  Eighty percent of these 
worms contained at least one misplaced ALM.   
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Figure 7:  Location of ALMs and AVM in Wild-type and mig-10 Mutant Worms.  Schematic of 
ynIs53; him-5 worm in wild-type (top) and mig-10 mutant (bottom) background. 
 
Excretory canal growth 
 One mig-10 mutant phenotype that is 100% penetrant is the foreshortened processes of 
the excretory cells.  In the wild-type worm, these processes extend through the length of the 
worm, stopping almost at the end of the worm’s tail.  The bgIs312 array expresses GFP in the 
excretory cell processes.  A strain was constructed to visualize the outgrowth defects of the mig-
10 (ct41) excretory cell processes by crossing mig-10 (ct41) into bgIs312.   
The excretory cell processes of 30 bgIs312 worms were all observed to run the length of 
the worm.  The processes observed in 30 worms confirmed to be homozygous for the mig-10 
mutant gene in the bgIs312 background all contained excretory cell processes that came to an end 
near or anterior to the vulva. 
 
Observation of AIYs 
The AIY neurons in the head were observed for any effects of mig-10 because another 
lab had previously reported that they were affected by mig-10 (O. Hobert, personal 
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communication).  To determine if the AIY neurons are affected, mig-10 (ct41) mutant worms 
were crossed with mgIs18 worms, in which GFP is expressed in the AIYs.  PCR (followed by an 
Hpy188I digest) was performed to confirm that the mig-10 gene was homozygous.    
   The AIY neurons in 50 mgIS18 worms were observed and compared to those in 50 
mgIs18; mig-10 (ct41) mutant worms.  There did not appear to be any difference between the two 
strains; it was concluded that the mig-10 mutant gene does not affect the AIYs. 
 
Observation of IL2s 
Previous results showed that IL2 neurons are defective in mig-10 mutant animals; this 
aspect of the phenotype is partially penetrant (Rusiecki, 1999).  To confirm these results, the IL2 
neurons were compared between the wild-type (N2) and mig-10 mutant (BW0315) worms after 
they had been DiO stained (see Methods).  A wild-type IL2 neuron has a dendrite that extends 
from the nose of the worm to a cell body (in the head); an axon extends from the cell body to the 
nerve ring (or brain) where it then loops back and branches to form connections with other 
neurons (fig. 8A-8C).  In the mig-10 mutant, the majority of an IL2 neuron may be present, but 
the loop is absent (fig. 8D).   In observing 42 wild-type worms, 100% were observed to contain 
normal IL2 processes.  In observing 47 mig-10 (ct41) worms, ~30% appeared to have at least one 
IL2 neuron that lacked the loop.     
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Figure 8:  IL2 Neurons in Wild-type and mig-10 Mutant Worms.  A) Schematic of wild-type IL2 
neurons.  B-D) Photomicrographs of wild-type (B & C) and mig-10 mutant (D) worms stained using DiO to 
visualize IL2 neurons.  Note the absence of the loop in D (arrow).  DiO-positive cells in the right upper 
corner of B-D – which are posterior to the IL2s – are the worm’s amphid neurons; these were not of interest 
in observing the IL2s. 
 
Construction of Strain Containing Genomic mig-10::GFP Fusion for Expression 
Analysis 
One goal of this project was to determine the expression pattern of mig-10.  In order to 
study this gene and how it works to allow for the proper migration of neurons and development of 
different cell types, it is important to learn in which cells this gene is expressed.  The mig-10 gene 
contains three transcripts, mig-10 A, B, and C (fig. 9).  The mig-10 C gene was not used in any of 
the experiments mentioned in this paper as it has just recently been discovered (wormbase, 2004).  
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As indicated in Manser et al., 1997, mig-10 B genomic DNA was believed to be sufficient to 
rescue the mig-10 mutant phenotype back to the wild-type.  Thus, DNA constructs were made (by 
Chris Burket) to contain mig-10 B genomic DNA and GFP, which would rescue at least some 
aspect of the mutant phenotype back to the wild-type.  The expression pattern of a rescuing 
construct is desired as this suggests that the expression pattern is correct.   
 
 
 
 
 
Figure 9:  Map of mig-10 Genes.  Diagram of mig-10 C (F10E9.6c), mig-10 A (F10E9.6a), and mig-10 B 
(F10E9.6b) DNA taken from Worm Base 
(http://www.wormbase.org/db/seq/sequence?name=F10E9.6a;class=CDS).  The mig-10 A gene contains an 
alternate first exon and promoter located further upstream than that of the mig-10 B gene.  Regions used as 
mig-10 A and B promoters are shown above.  The mig-10 B promoter region is mistakenly shown as an 
exon; this is a database error.  
 
To determine if mig-10 B genomic DNA would rescue the mig-10 mutant back to the 
wild-type phenotype, a plasmid containing the mig-10 promoter and GFP was co-injected with a 
plasmid containing GFP and the mig-10 B genomic DNA into mig-10 mutant worms (fig. 10).  A 
third plasmid that was co-injected contained the elt-2 promoter and GFP; this plasmid served as a 
mig-10 B 
promoter 
mig-10 A 
promoter 
 
 
mig-10         
    C 
mig-10  
   A 
mig-10  
   B 
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co-injection marker.  The resulting extrachromasomal arrays were designated mpEx15, mpEx16, 
and mpEx17.   
 
 
Figure 10:  DNA Constructs Used in Expressing Wild-type mig-10 Gene in mig-10 Mutant Worms. 
Schematic of DNA constructs used in an attempt to determine the expression pattern of mig-10.  The mig-
10 B promoter and genomic DNA were placed on two different plasmids because the DNA was too long 
for one plasmid.  Recombination at the GFP site on the two plasmids allowed for the promoter to be 
positioned next to the genomic DNA (with GFP between them) (C. Burket, 2002).  The co-injection marker 
(containing the elt-2 promoter) allowed the worm’s intestinal cells (where elt-2 is expressed) to fluoresce 
green (via GFP), thereby revealing that the worm contains the extrachromasomal DNA.  The GFP found on 
the other plasmids with mig-10 is also expressed, but is very weak and difficult to observe in the larval and 
adult worms. 
 
The RY56 strain carries the mpEx15 array in the mig-10 (ct41) background.  This strain 
was examined for rescue of neuron morphology.  The results can be seen in table 3. 
Because the transgenic array was not integrated into the chromosome, it was lost in some 
meioses.  This allowed a direct comparison between worms carrying the array and those that had 
lost it.  The percentage of worms with abnormal IL2 processes was 43% in nontransgenic worms 
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and 17% in transgenic worms (table 3, rows 1 and 2).  To determine if this difference was 
statistically significant, a chi-  
		  	ﬀ	ﬂﬁﬃ! #"$%&'&('%)%&	 * 2 value did not quite 
reach significance (0.05 < p < 0.10), the data looked promising, and as the p value was 
approaching the 0.05 level (in which the data would have been accepted as significantly 
different), the rescue experiments were continued.             
 
 Defective Non-defective Total 
mig-10 
Lost Transgene 
15 
(43%) 
20 
(57%) 
35 
mig-10 (ct41); mpEx15 
Nonintegrated 
Transgenic 
4 
(17%) 
19 
(83%) 
23 
mig-10 (ct41); mpIs5 
Integrated 
Transgenic  
12 
(24%) 
38 
(76%) 
50 
 
Table 3:  mig-10 B Genomic DNA Did Not Rescue Defective IL2 Neuronal Processes.  Worms were 
DiO stained and the phenotype of the IL2s was determined without knowledge of the transgene’s presence.  
Though there was a decrease in the percentage of worms with defective processes in the mig-10; mpEx15 
nonintegrated transgenic worms, the P value from the chi-square tests (0.05 <P<0.10) indicated that this 
difference was not significant.  The integration of the mig-10 B plasmid DNA into the genome of C. 
elegans
 to generate mig-10 (ct41); mpIs5 did not rescue mig-10 mutants back to the wild-type phenotype.  
The second chi square test, which was performed on all three rows of data from this table, confirmed that 
there was no significant difference in the percentage of defective worms between the two transgenic and 
the nontransgenic strains (0.10<P<0.20). 
 
Observation of Excretory Canal
 
 Three different nonintegrated transgenes containing mig-10 B genomic extrachromasomal 
DNA were constructed (mpEx15, mpEx16, and mpEx17).  To determine whether any of these 
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transgenes rescue the excretory canal defect of mig-10 (ct41), they were crossed with the bgIs312 
strain, in which the excretory canal fluoresces green.  PCR (followed by an Hpy188I restriction 
digest) was used to confirm that the mig-10 mutant gene was homozygous in all three strains; the 
expected fragment sizes are seen in appendix A.  Figure 11 shows the results of this digest of the 
PCR product from mig-10; mpEx17; bgIs312.  The other lines were checked by the same assay. 
 
 
 
Figure 11:  Confirmation of Genotype of mig-10 (ct41); mpEx17; bgIs312.  PCR products from all 
strains were digested with Hpy188I.  Lane 1, 100 bp Ladder.  Digested PCR products show that a 400 bp 
band is only observed with the N2 (wild-type) samples (lanes 2 and 3) (Appendix A).  The mig-10 
homozygous mutants, on the other hand, display a strong band at about 600 bp (lanes 4 and 5).  Lanes 6 
through 9 contain the Hpy188I-digested PCR product from mig-10 (ct41); bgIs312 worms that had lost the 
nonintegrated array.  PCR was performed with the worms that had “lost” the extrachromasomal DNA (the 
extrachromasomal DNA had not been inherited from the parental generation) so that the genomic mig-10 
DNA, and not the extrachromasomal DNA would be replicated.   
 
The excretory canal in these strains containing bgIs312 was observed in 30 worms for 
each strain. Thirty out of thirty mig-10 (ct41); mpEx15; bgIs312 and mig-10 (ct41); mpEx17; 
bgIs312 worms were found to have a foreshortened excretory canal.  Only one out of thirty mig-
10 (ct41); mpEx16; bgIs312 worms was observed to have a full-length excretory canal.  This 
wild-type mutant 
400 bp 
700 bp 
600 bp 
400 bp 
 32 
result shows that the mig-10 B genomic DNA does not rescue the mig-10 mutant excretory canal 
phenotype. 
 
Results of Integrating mig-10 B DNA into C. elegans’ Genome  
The DiO staining of the IL2 neurons suggested that there might be partial rescue of this 
aspect of the mig-10 (ct41) phenotype by the mig-10 B genomic construct.  Extrachromosomal 
arrays usually exhibit mosaicism due to loss of the array from some cells during mitosis.  Thus, 
the array was integrated into the genome to determine whether this would result in complete 
rescue (see Methods).  The integrated transgene is denoted mpIs5. 
After the integration of the mig-10 B gene into the genome, the IL2s of 50 mig-10 (ct41); 
mpIs5 worms were observed.  As table 3 shows, there was a decrease in the percentage of worms 
containing defective IL2s in the mig-10 (ct41) nontransgenic worms as compared to the mig-10 
(ct41); mpIs5 strain.  In comparing the mig-10 (ct41); mpEx15 transgenic worms to mig-10 
(ct41); mpIs5, however, it was observed that the integration of the mig-10 B DNA did not rescue 
mutant IL2s back to the wild-type phenotype.  To confirm this, a chi square test was performed 
on all of the data in table 3.  The chi square value was 4.04 with 2 degrees of freedom.  The P 
value was greater than 0.10 (0.10<P<0.20).  As a result, the null hypothesis - the percentage of 
worms with the mutant phenotype is not significantly different between the two transgenic and 
the nontransgenic animals - was accepted. 
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Construction of mig-10 A & mig-10 B cDNA with mec-3 Promoter for Cell 
Autonomy Experiments 
 Preliminary analysis of both mig-10 (ct41); mpIs5 and dpy-20 (e1282ts); mpIs1 
(containing the mig-10 B promoter driving GFP) suggested mig-10 is expressed in neurons.  This 
observation suggested that, unlike the case in the excretory canal, mig-10 might act cell 
autonomously in neurons.  To test this hypothesis for ALM migration, it was desired to 
specifically express mig-10 cDNA in ALMs.  Rescue of the mutant back to the wild-type 
phenotype would indicate that the MIG-10 protein functions within the ALMs.  No rescue 
occurring would suggest that the protein needed to be in another cell for the proper placement of 
ALMs.   
The mec-3 promoter was used to drive expression of the mig-10 A and mig-10 B cDNA 
constructs because this promoter drives expression in the ALMs, AVM, and only a few other 
cells in the early development of C. elegans.  Vectors containing mig-10 A and B were kindly 
provided by Chris Quinn.  The presence of mig-10 A and B were verified by restriction digestion 
(fig. 12).  pPD57.56, a vector containing the mec-3 promoter, was kindly provided by Andy Fire.  
Both the vector pPD57.56 and mig-10 A and B cDNA-containing vectors were digested with 
KpnI and NheI (see Methods).  The appropriate fragments were gel purified and ligated to create 
the desired mec-3::mig-10 constructs (Appendix D). 
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Figure 12:  Confirmation of mig-10 A and mig-10 B Initial Constructs.  SspI digest of mig-10 A (lanes 4 
and 5) and mig-10 B (lanes 6 and 7) cDNA-containing pCRII-TOPO plasmids.  The pCRII-TOPO vector 
does not contain an SspI restriction site, but the mig-10 A sequence contains two, yielding a 900 base pair 
(bp) and 5.1 kilobase (kb) fragment (Appendix B).  There is only one SspI site in the mig-10 B-containing 
pCRII-TOPO plasmid, yielding a single band of about 6.0 kb (Appendix B).  DNA bands of these 
approximate sizes were obtained, as seen in the figure.  The 100 bp and 1.0 kb Ladders are seen in lanes 2 
and 3, respectively.  (Lane 1 contains EcoRI/SpeI-digested pflp-20 DNA.)   
 
Following the confirmations that plasmids containing the mec-3 promoter and the mig-10 
cDNA had been obtained (fig. 13), each type of plasmid (the one containing mig-10 A, and the 
other containing mig-10 B) was separately combined with the pflp-20 plasmid.  The mixture 
containing pflp-20 and one of the mec-3::mig-10 plasmids was injected into N2 worms, as 
described in the Methods section.  As a result of these injections, one line containing the mig-10 
A cDNA (mpEx12, referred to as the A1 line), and two lines containing the mig-10 B cDNA 
(mpEx13 and mpEx14, referred to as the B1 and B8 lines, respectively) were obtained.   
 
pflp-20 
marker
s 
mig-10 A mig-10 B 
900 bp 
5.1 kb 
6.0 kb 
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Figure 13:  pPD57.56 + mig-10 Digested to Completion with SspI and HindIII.  Panel S, miniprep DNA 
digested with SspI.  Panel H, miniprep DNA digested with HindIII.  V, vector pPD57.56 alone; B, vector + 
mig-10 B cDNA insert; A, vector + mig-10 A cDNA insert.  Lanes 1 and 2 (S and H) contain a 100 bp and 
1.0 kb DNA Ladder, respectively.  (See Appendixes C and D). 
 
mec-3::mig-10 Constructs Partially Rescue Defective ALM Migration in mig-10 
Mutants  
 To determine whether the mec-3::mig-10 cDNAs had any detrimental effect in a wild-
type background, the relative positions of the ALMs and AVM were observed in 30 worms for 
each line (table 4).  Thirty out of thirty worms from the B1 and A1 lines were observed to have 
ALMs that were posterior to the AVM (the wild-type phenotype).  One out of thirty worms in the 
B8 line contained a misplaced ALM.  This wild-type phenotype was important to demonstrate, as 
overexpressed wild-type DNA can result in a mutant phenotype. 
 The mig-10 mutation was crossed into the A1, B1, and B8 strains to create strains mig-10 
(ct41); mpEx12, mig-10 (ct41); mpEx13, and mig-10 (ct41); mpEx14 respectively, which are 
referred to as A1; mig-10, B1; mig-10, and B8; mig-10.  PCR (followed by an Hpy188I restriction 
digest) was used to confirm that this mutant gene was homozygous in each strain (data not 
S H 
V B A 
 
V B V A 
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shown).  Fifty worms from each of the three lines containing the mig-10 mutation - at about the 
L4 stage - were observed for the relative positions of the ALMs and AVM (table 4).  All three 
strains containing the wild-type cDNA in the mig-10 mutant background appeared to show partial 
rescue of the ALMs when compared with the strain containing mig-10 (ct41) and the flp-20 
construct with no rescuing mig-10 (table 4).  The rescuing array strains were significantly 
different both from wild-type strains and from mutant strains (table 5).    The strains with the 
rescuing DNA (lines B1; mig-10, B8; mig-10, and A1; mig-10) displayed varying levels of 
misplaced ALMs.  The A1; mig-10 strain had the highest number of misplaced ALMs (50%), 
which was significantly below the number of mutants observed in the mig-10 (ct41); ynIs534 
strain (80%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 37 
Row # Strain Defective Nondefective Total 
1 ynIs534; him-5 6 
(12%) 
44 
(88%) 
50 
2 mig-10 (ct41); 
ynIs534 
40 
(80%) 
10 
(20%) 
50 
3 B1 0 30 30 
4 B1:mig-10 21 
(42%) 
29 
(58%) 
50 
5 B8 1 29 30 
6 B8:mig-10 18 
(36%) 
32 
(64%) 
50 
7 A1 0 30 30 
8 A1:mig-10 25 
(50%) 
25 
(50%) 
50 
 
Table 4:  Partial Rescue of Defective ALM Migration.  Defective worms were scored as those in which 
at least one of the ALMs is either anterior to the AVM or equidistant from the worm’s nose with th e AVM.  
ynIs534 is an integrated array containing pflp-20:: GFP, which is a marker for ALM and other touch 
neurons.  him-5 is a mutation that creates a higher incidence of males in the strain and does not affect ALM 
migration.  A1, B1, and B8 are extrachromasomal arrays containing mec-3::mig-10 A or B cDNA and pflp-
20::GFP constructs.   
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Test Row # X2 P 
1 1, 2 43.84 < 0.001 
2 3, 4 14.98 < 0.001 
3 5, 6 9.32 0.001<P<0.01 
4 7, 8 19.54 < 0.001 
5 2, 4 13.62 < 0.001 
6 2, 6 18.1 < 0.001 
7 2, 8 8.62 0.001<P<0.01 
 
Table 5:  Chi Square Values/Significance of Data in Table 4.  This data corresponds to the data in table 
4.  In order to confirm that there was a significant difference in the percentage of misplaced ALMs between 
the wild-type ynIs534; him-5 and the mutant mig-10 (ct41); ynIs534, a chi square test was performed (test 
1).  Other chi square tests were done to verify that the percentage of misplaced ALMs between each of the 
mutant strains containing a potential rescuing plasmid (B1:mig-10, B8:mig-10, and A1:mig-10) and the 
wild-type worms containing the appropriate mec-3::mig-10 rescuing plasmid constructs (B1, B8, and A1) 
were significantly different (tests 2, 3, 4).  Additional chi square tests were done to verify that there was a 
significant difference in the percentage of worms with misplaced ALMs between the mutant worm strain 
mig-10 (ct41); ynIs534 and the mutant worms containing one of the mec-3::mig-10 rescuing plasmid 
constructs (B1:mig-10, B8:mig-10, and A1:mig-10) (tests 5, 6, and 7).  The chi square (X2) and p values, 
and the rows (from table 4) for which the tests were performed are seen above. 
 
Confirmation of mig-10 cDNA Vectors with mig-10 Promoters 
 As the pPD57.56 vectors with the inserted mig-10 cDNA appeared to only result in 
partial rescue of the ALM position, these vectors were used to insert either a mig-10 A or B 
promoter in the place of the mec-3 promoter region (Appendix E).  These new vectors, 
constructed by Turkan Arca, allow the hypothesis that mig-10 A and mig-10 B may rescue 
different aspects of the mig-10 (ct41) phenotype to be tested.  As the mig-10 promoter should 
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allow the mig-10 cDNAs to be expressed where necessary, nearly a 100% rescue of the ALMs 
would be expected in the worms in which these vectors would be injected.   
   To confirm that each vector contained the appropriate mig-10 cDNA region, PCR was 
performed on the vector containing the mig-10 A promoter with mig-10 A cDNA, and the vector 
containing the mig-10 B promoter with mig-10 B cDNA (fig. 14).  Each vector containing a mig-
10 promoter and mig-10 cDNA was also digested with SpeI in order to confirm that they 
contained the appropriate promoter (fig. 15).  Thus, the vectors were confirmed to contain the 
appropriate mig-10 regions. 
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Figure 14:  PCR Products from mig-10 A and B cDNA.  The expected PCR product from the vector with 
the mig-10 A cDNA was about 240 bp.  Lane 3 contains PCR product (between 200 and 300 bp) using the 
mig-10 tran B primer and mig-10 exon A primer with the mig-10 A cDNA.  The PCR product from the 
vector with the mig-10 B cDNA was expected to be about 186 bp.  A DNA band (~200 bp) is seen as the 
PCR product using the mig-10 tran B primer and mig-10 exon B primer with the mig-10 B cDNA (lane 4).  
As a control, each set of primers was used with the other mig-10 cDNA, from which no PCR product was 
expected (lanes 5 and 6).  Another control used was the primers without any template DNA (lanes 7 and 8).  
Faint bands observed in lanes 5-8 were believed to be either the result of the primers loosely annealing to a 
similar sequence as what is found in the original vector used with the primers, or primer dimer.  Lanes 1 
and 2, 1.0 kb and 100 bp Ladder, respectively.  (Refer to the Appendix F for where the primers anneal to 
the mig-10 cDNA regions.) 
 
 
 
 
 
 
 
 
mig-10 
    A  
mig-10     
    B 
negative controls 
100 bp   
300 bp 240 
~200 
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Figure 15:  Vector with mig-10 A Promoter and cDNA & Vector with mig-10 B Promoter and cDNA 
Digested with SpeI.  Lane A, 100 bp Ladder; Lanes B-D, 1.0 kb Ladder; Lanes E-I, SpeI digested mig-10 
A promoter + cDNA vector, (Expected bands:  6,318 bp, 3,973 bp, 473 bp, and 13 bp; Actual bands:  6.0-
7.0 kb, 4.0 kb, and 500 bp; 500 bp band shown by yellow arrow.)  Lanes J-N, SpeI digested mig-10 B 
promoter + cDNA vector, (Expected band:  10.5 kb; Actual band:  ~10.0 kb). 
 
 
 
 
 
 
 
 
  
 
 
 
6.3 
marker
s 
mig-10 A mig-10 B 
~ 10.0 kb 
~ 6.32 kb 
~ 4.0 kb 
~ 500 bp 
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Discussion 
 
 
 mig-10 is required for the migration of certain neurons including the ALMs, the 
outgrowth of the excretory canal, and axon outgrowth of the IL2s (Manser et al., 1997); 
(Rusiecki, 1999).  In order to understand how mig-10 functions, its phenotype, expression pattern, 
and cell autonomy were examined.  As mig-10 A and B have different promoters, the MIG-10 
proteins differ in their N-termini, and MIG-10 A has a second proline-rich region, it would not be 
unreasonable to suggest that mig-10 A and B would be expressed and function differently.   
 
Expression Pattern 
In order to determine the most accurate expression pattern, plasmid constructs containing 
a mig-10 promoter, genomic wild-type mig-10 B DNA, and a GFP region were injected into C. 
elegans.  The mig-10 A DNA was not used as previous experiments indicated that the mig-10 B 
DNA alone was sufficient for rescue of mig-10 (ct41) mutant phenotypes back to the wild-type 
phenotype (Manser et al., 1997).  However, these constructs, even when integrated, appeared to 
give only partial rescue of IL2 mutant phenotypes, and no rescue of the excretory canal mutant 
phenotype.   
This lack of rescue could be due to a lack of the necessary amount of expression of the 
mig-10 B genomic construct.  Another possibility includes an incorrect sequence contained within 
the mig-10 B genomic construct, as its sequence has not been checked.  Also, as there is more 
than one mig-10 transcript, different transcripts may be needed to rescue the different aspects of 
the mig-10 mutant phenotype.  For example, complete rescue may actually require the mig-10 A 
transcript, in addition to mig-10 B.  Despite the lack of complete rescue, the strain obtained from 
the integration of the DNA may be useful for expression pattern studies. 
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Cell Autonomy 
Analysis of transgenic lines containing mig-10 promoter::GFP or mig-10 B 
genomic::GFP suggested the expression of the gene is mostly in neurons.  Thus, cell autonomy 
experiments focused on expressing mig-10 specifically in affected neurons to see if this would 
rescue the mig-10 mutant phenotype back to the wild-type phenotype.  As the mig-10 gene is 
believed to produce a protein involved in signal transduction, it seems that this gene should be 
cell autonomous.  However, mig-10 is known to be cell nonautonomous in excretory cell 
outgrowth (Manser et al., 1997).  Models showing how mig-10 might function cell autonomously, 
cell nonautonomously, or both are shown in figure 16.  
In determining which neurons would be ideal for experiments in cell autonomy, the AIY 
neurons were rejected as there was no significant difference between the wild-type and mig-10 
(ct41) mutants.  The ALMs, on the other hand, became a focal point for cell autonomy as only 
12% of the wild-type worms appeared to have misplaced ALMs, and 80% of the mig-10 mutant 
worms had misplaced ALMs.   
A mec-3 promoter was used to force the expression of mig-10 A or B in ALM neurons.  
After the mec-3::mig-10 A DNA or mec-3::mig-10 B DNA-injected worms (in which mig-10 was 
expressed in the ALMs) were crossed with mig-10 (ct41) mutant worms, partial rescue of the 
ALM migration defect to the wild-type was seen in the two lines containing mig-10 B cDNA and 
the one line containing mig-10 A cDNA.  This partial rescue could be due, again, to the need for 
both of the mig-10 transcripts to be expressed in one cell, or for one or both transcripts to be 
expressed  in a cell nonautonomous fashion in addition to being expressed cell autonomously.  
Other possibilities include a low production of the rescuing protein, or expression of the protein at 
a developmental stage that is not early enough for complete rescue of the mig-10 mutant back to 
the wild-type.    
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Both Cell Autonomous & Cell Nonautonomous 
Figure 16:  Proposed Models of How MIG-10 May Function as a Signal Transduction Protein.  mig-10 
may act in a cell autonomous, or cell nonautonomous fashion, or may use a combination of cell autonomy 
and cell nonautonomy.  If mig-10 is cell autonomous, then the protein will function in the cell that requires 
it for proper function or development.  For example, MIG-10 protein might be required in the growth cone 
of a neuron to transduce a guidance signal affecting that cell.  A cell nonautonomous protein functions in a 
cell other than the one that requires the expression of that protein.  For example, mig-10 might facilitate the 
secretion of a guidance signal that acts on the neuron’s growth cone.  One other possibiltiy (not  shown) is 
that MIG-10 A and B may both be needed in the same cell.   
Cell Autonomous 
Cell Nonautonomous 
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 If the cDNA constructs are fully functional, and were expressed wherever they were 
needed, complete rescue of the mig-10 mutant back to the wild-type phenotype would be 
expected.  Results from another lab, in which the A1; mig-10, B1; mig-10, and B8; mig-10 strains 
were observed for AVM axon defects, showed that either mec-3::mig-10 construct results in 
complete rescue of these axon defects (C. Quinn, personal communication).  This suggests that 
the rescuing constructs express fully functioning MIG-10 A and MIG-10 B proteins.  To 
determine if the individual mig-10 transcripts rescue different aspects of the mig-10 (ct41) 
phenotype, the mec-3 promoter in the mig-10 A and mig-10 B cDNA constructs was replaced with 
mig-10 promoters (work of Turkan Arca), though these constructs have not yet been used in any 
experiments.  For example, mig-10 A might rescue defective neurons, while mig-10 B could 
rescue a mutant excretory canal.  Another experiment in progress is the injection of mig-10 
promoter::mig-10 A and mig-10 promoter::mig-10 B together.  This should correct any partial 
rescue that may be due to the lack of both MIG-10 proteins. 
Though few conclusions have been made about the cell autonomy of mig-10 (ct41), and 
the expression pattern of this gene has yet to be fully determined, the groundwork for these 
projects has been laid.  An integrated mig-10 B genomic line was obtained and can be used for 
expression studies.  The partial rescue obtained in the various experiments is confusing and 
intriguing.  Further experiments may lead to a better understanding of how mig-10 A differs from 
mig-10 B (and possibly mig-10 C), and mig-10’s role in the migration of neurons and axon 
guidance.  
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Appendix A 
Map of mig-10 (mutant & wild-type) gene with Hpy188I restriction sites 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
The primers used in the PCR of the mig-10 gene were MIG10-WT1 and MIG10-WT2.  The 
genetic sequence of MIG10-WT1 is 5’ -TGTTTGAATTTTCAGAATCCGC-3’, and that of the 
MIG10-WT2 primer is 5’ -TGTTTCTTCTCACAATCCAACC-3’.  (These maps were taken from 
the MQP project of Romiya Glover and Stephanie Morin.) 
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Map of mutant mig-10 Hpy188I restriction sites 
Map of mig-10 wild-type Hpy188I restriction sites 
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Appendix B 
Maps of mig-10 A and B cDNA in PCRII-TOPO vector 
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mig-10 A in PCRII-TOPO
6036 bps
HindIII 276
KpnI 282
EcoRI 325
KpnI 339
HindIII 366
SspI 1370
HindIII 1515
SspI 2271
NheI 2390
EcoRI 2406
EcoRV 2416
XhoI 2439
mig-10 A cDNA
PCRII-TOPO vector
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mig-10 B cDNA in PCRII-TOPO
5991 bps
HindIII 276
KpnI 282
EcoRI 325
KpnI 339
HindIII 366
SspI 1370
HindIII 1515
NheI 2345
EcoRI 2361
EcoRV 2371
XhoI 2394
mig-10 B cDNA
PCRII-TOPO vector
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Appendix C 
pPD57.56 vector  
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pPD57.56
5304 bps
HindIII 18
SphI 24
PstI 30
KpnI 35
SspI 797
SphI 1233
HindIII 1323
XbaI 1779
SphI 1801
BamHI 1935
SmaI 1940
BalI 1948
NheI 2019
SalI 2025
KpnI 2031
SacI 2052
EagI 2063SpeI 2822
EagI 2828
ApaI 2837
AflII 3090
SspI 3268
PvuII 5141
MCS I w ith mec-3 promoter
MCS II
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Appendix D 
pPD57.56 vector with inserted mig-10 A and B cDNA 
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pPD57.56 + mig-10 A cDNA
7343 bps
HindIII 18
SphI 24
PstI 30
KpnI 35
SspI 797
SphI 1233
HindIII 1323
XbaI 1779
SphI 1801
BamHI 1935
SmaI 1940
BalI 1948
NheI 2019
BamHI 2056
SspI 2138
PvuII 2421
HindIII 2894
SspI 3039
XbaI 3736
HindIII 4043
KpnI 4070
EcoRV 4084
SacI 4091
SpeI 4861
ApaI 4876
AflII 5129
SspI 5307
PvuII 7180
MCS I w ith mec-3 promoter
mig-10 A cDNA
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pPD57.56 + mig-10 B cDNA
7298 bps
HindIII 18
SphI 24
PstI 30
KpnI 35
SspI 797
SphI 1233
HindIII 1323
XbaI 1779
SphI 1801
BamHI 1935
SmaI 1940
BalI 1948
NheI 2019
PvuII 2376
HindIII 2849
SspI 2994
XbaI 3691
HindIII 3998
KpnI 4025
EcoRV 4039
SacI 4046
SpeI 4816
ApaI 4831
AflII 5084
SspI 5262
PvuII 7135
MCS I w ith mec-3 promoter
mig-10 B cDNA
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Appendix E 
Vectors containing mig-10 A promoter::mig-10 A cDNA  
& mig-10 B promoter::mig-10 B cDNA 
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mig-10 A promoter + mig-10 A 
10777 bps
SpeI 3802
SpeI 4275
SpeI 4288
PpuMI 5409
NheI 5419
KpnI 7470
NcoI 7474
EcoRV 7484
SacI 7491
SpeI 8261
ApaI 8276
SspI 8707
PvuII 10580
HindIII 10761
SphI 10767
PstI 10773
mig-10A
mig-10Apromoter
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mig-10 B promoter + mig-10 B
10501 bps
SmaI 5109
BalI 5117
PpuMI 5124
PpuMI 5178
NheI 5188
KpnI 7194
NcoI 7198
EcoRV 7208
SacI 7215
SpeI 7985
ApaI 8000
SspI 8431
PvuII 10304
HindIII 10485
SphI 10491
PstI 10497
mig-10B
mig-10Bpromoter
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Appendix F 
Primers annealing to vector containing mig-10 A promoter::mig-10 A cDNA and 
mig-10 B promoter::mig-10 B cDNA 
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mig-10 A promoter + mig-10 A 
10777 bps
SpeI 3802
SpeI 4275
SpeI 4288
PpuMI 5409
NheI 5419
KpnI 7470
NcoI 7474
EcoRV 7484
SacI 7491
SpeI 8261
ApaI 8276
SspI 8707
PvuII 10580
HindIII 10761
SphI 10767
PstI 10773
mig-10A
mig-10 exon A primermig-10 tran B primer
mig-10Apromoter
 
 
 The mig-10 tran B primer anneals to both the mig-10 A and B cDNA sequences.  The primer mig-
10 exon A anneals only to mig-10 A cDNA, as mig-10 exon B primer anneals only to mig-10 B 
cDNA.   The mig-10 exon A primer sequence is 5’ -ACCATGGACACTTACGACTTCC-3’.     
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mig-10 B promoter + mig-10 B
10501 bps
SmaI 5109
BalI 5117
PpuMI 5124
PpuMI 5178
NheI 5188
KpnI 7194
NcoI 7198
EcoRV 7208
SacI 7215
SpeI 7985
ApaI 8000
SspI 8431
PvuII 10304
HindIII 10485
SphI 10491
PstI 10497
mig-10B
mig-10 exon B primer
mig-10 tran B primer
mig-10Bpromoter
 
  
The sequence of the mig-10 tran B primer is 5’ -GGCTAGAAGAAGCTGGAATCCCG-3’.    The 
mig-10 exon B primer sequence is 5’ -AATGTATCACGATCGACGGCG-3’.  
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